SoSTART is a randomised controlled trial for adults with atrial fibrillation after a brain haemorrhage.

Watch and listen to a 9-minute interview with the Chief Investigator about how to explain the therapeutic dilemma about oral anticoagulation for atrial fibrillation after intracranial haemorrhage. He covers these topics:

1. Who should explain this to a patient or carer?
2. When is the best time to discuss this?
3. What can we tell patients who were taking anticoagulation before their bleed about the cause of their haemorrhage?
4. What can we tell patients about the benefits of oral anticoagulation?
5. What can we tell patients about the hazards of oral anticoagulation?
6. How can we describe the balance between benefits and hazards?
7. What can we tell patients about their standard care?
8. How can the dilemma be resolved?